MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

Catalent Signs Agreement to Take Over Juniper Pharmaceuticals, Inc

    Catalent Signs Agreement to Take Over Juniper Pharmaceuticals, Inc

Catalent, Inc, on Monday, signs an agreement to acquire Juniper Pharmaceuticals, Inc. along with its UK-based center in Nottingham. Catalent wrapped up the deal for $ 11.50 per share in cash.

“Juniper’s proven solutions and capabilities will further support Catalent’s strategic goal to be the most comprehensive partner for pharmaceutical innovators,” said Jonathan Arnold, President of Catalent Oral Drug Delivery.

With the acquisition, Catalent will boost its offerings in the field of formulation development, bioavailability, and robot manufacturing and will balance its amalgamated global clinical and business supply units.

In its Nottingham centre, Juniper accommodates around 150 workers which are specialized in the field of formulation development. Hence, it’s an added advantage to the company for having a team of skilled workers, as they are responsible for redefining the old profile.

The old profile includes sophisticated transmission, articulation, formulation, critical, and pharmacology improvement solutions, including augmentation of integrated development, reasonable, and technical manufacturing.

Catalent deals with technology and development solutions for medicines and consumer health goods across the world. It has branches over several countries which include the UK, the USA and several parts of Asia and Europe.

“Juniper’s scientific expertise in early-phase product development and supply will help our customers to unlock the full potential of their molecules and provide better and faster treatments to patients,” said Mr. Arnold.

 

 

 

 

 

 

 

 

 

 

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED